VBIV - Spark Newswire

1 minute read

VBI Vaccines Announces Initiation Of Phase 1 Study Of Multivalent Coronavirus Vaccine Candidate, VBI-2901

September 29, 8:09 AM

Initiation of first clinical study of multivalent VBI-2901, designed to increase breadth of protection against COVID-19 and related coronaviruses Preclinical data support broadly reactive immunity of VBI-2901 against

VBIV

1 minute read

VBI Vaccines Announces Presentation Of Physician-Initiated Compassionate Use Data Of 3-Antigen Hepatitis B Vaccine At 2022 International HBV Meeting; Presentation Was Monday, Sept. 19

By Benzinga Newsdesk

September 21, 8:05 AM

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced that data from the physician-initiated

VBIV

3 minute read

VBI Vaccines Secures $100M Debt Facility From K2 HealthVentures

By Benzinga Newsdesk

September 15, 8:31 AM

VBI Vaccines Inc. (NASDAQ:VBIV) (VBI), a biopharmaceutical company driven by immunology in the pursuit of powerful prevention and treatment of disease, today announced it has entered into a refinanced and upsized debt

VBIV

3 minute read

Why Hill International Is Trading Higher By 15%; Here Are 30 Stocks Moving Premarket

By Lisa Levin

August 29, 5:35 AM

Gainers NewAge, Inc. (NASDAQ: NBEV) shares rose 19.7% to $0.2432 in pre-market trading. NewAge recently received Nasdaq notice on late filing of its form 10-Q.

AVCT

1 minute read

News

VBI Vaccines Says On August 26, 2022 Co. Delivered Written Notices To Jefferies To Terminate Each Of July 2022 Sales Agreement, September 2021 Sales Agreement, Effective Aug. 26, 2022

By Michael Horton

August 26, 4:47 PM

-SEC Filing

VBIV

5 minute read

This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday

By Lisa Levin

August 19, 3:54 AM

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.

ALLR

3 minute read

Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

August 18, 12:54 PM

Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.

AURA

1 minute read

Bed Bath & Beyond, America’s Car-Mart And Some Other Big Stocks Moving Lower On Thursday

By Lisa Levin

August 18, 11:39 AM

Bed Bath & Beyond Inc. (NASDAQ: BBBY) fell 23.3% to $17.71 following a Form 144 filing by RC Ventures, which suggested the firm proposed to sell 7.78 million common shares and certain call options. Additionally, Wedbush downgraded the stock to Underperform.

AMTD